{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:46:40Z","timestamp":1792028800821,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01184-2","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:15:32Z","timestamp":1784711732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a GC\u2013MS method for the determination of ethylene glycol and diethylene glycol in pharmaceutical syrups"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6132-2758","authenticated-orcid":false,"given":"Muhammad Amirul","family":"Amil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahariz","family":"Mohamad Adzib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4277-6080","authenticated-orcid":false,"given":"Nur Baizura","family":"Bujang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-8684","authenticated-orcid":false,"given":"Kok Zheng","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6137-9137","authenticated-orcid":false,"given":"Sara Khalida","family":"Jamal Khair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malissa Wani","family":"Mohammad Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Zariq Syafiq","family":"Zaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7735-856X","authenticated-orcid":false,"given":"Ahmad Yusri","family":"Mohd Yusop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"1184_CR1","doi-asserted-by":"crossref","first-page":"105741","DOI":"10.1016\/j.yrtph.2024.105741","volume":"155","author":"P Kumar","year":"2025","unstructured":"Kumar P, Rastogi S, Saini PK, Sahoo S, Raghuvanshi RS, Jadaun GPS. Minimizing the risk of ethylene glycol and diethylene glycol poisoning in medications: A regulatory and pharmacopoeial response. Regul Toxicol Pharmacol. 2025;155:105741.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1184_CR2","doi-asserted-by":"crossref","first-page":"e27559","DOI":"10.1016\/j.heliyon.2024.e27559","volume":"10","author":"MA Altamimy","year":"2024","unstructured":"Altamimy MA, Alshehri YM, Aldawsari FS, Altalyan NH, AlShmmari SK, Alzaid SF, Al Shahrani MS. A selective gas chromatography\u2013tandem mass spectrometry method for quantitation of ethylene and diethylene glycol in paediatric syrups. Heliyon. 2024;10:e27559.","journal-title":"Heliyon"},{"key":"1184_CR3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/15563650.2021.1874403","volume":"59","author":"CN Jamison","year":"2021","unstructured":"Jamison CN, Dayton RD, Latimer B, McKinney MP, Mitchell HG, McMartin K. Neurotoxic effects of nephrotoxic compound diethylene glycol. J Clin Toxicol. 2021;59:810\u201321.","journal-title":"J Clin Toxicol"},{"key":"1184_CR4","doi-asserted-by":"crossref","first-page":"143699","DOI":"10.1016\/j.cej.2023.143699","volume":"468","author":"MK Wong","year":"2023","unstructured":"Wong MK, Lock SSM, Chan YH, Yeoh SJ, Tan IS. Towards sustainable production of bio-based ethylene glycol: Progress, perspective and challenges in catalytic conversion and purification. Chem Eng J. 2023;468:143699.","journal-title":"Chem Eng J"},{"key":"1184_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3345\/cep.2023.01522","volume":"67","author":"SR Soleman","year":"2024","unstructured":"Soleman SR, Adnan ML, Sudiarto HA, Mahathma SB, Tazkia AA, Firdaus HA, Choironi EA. Effects of diethylene glycol contamination of pharmaceutical products on unexplained acute kidney injury in children: A systematic review. Clin Experimental Pediatr. 2024;67:395.","journal-title":"Clin Experimental Pediatr"},{"key":"1184_CR6","first-page":"2867","volume":"55","author":"S de Almeida Ara\u00fajo","year":"2023","unstructured":"de Almeida Ara\u00fajo S, Faria BCD, Vasconcelos JC, da Cruz AF, de Souza VS, Wanderley DC. Sim\u00f5es-e-Silva AC. Renal toxicity caused by diethylene glycol: An overview. Int J Urol. 2023;55:2867\u201375.","journal-title":"Int J Urol"},{"key":"1184_CR7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-122-6-199503150-00009","volume":"122","author":"PM Wax","year":"1995","unstructured":"Wax PM. Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Ann Intern Med. 1995;122:456\u201361.","journal-title":"Ann Intern Med"},{"key":"1184_CR8","first-page":"88","volume":"311","author":"M Hanif","year":"1995","unstructured":"Hanif M, Mobarak MR, Ronan A, Rahman D, Donovan JJ Jr., Bennish ML. Fatal renal failure caused by diethylene glycol in paracetamol elixir: The Bangladesh epidemic. BMJ (Clinical Res ed). 1995;311:88\u201391.","journal-title":"BMJ (Clinical Res ed)"},{"key":"1184_CR9","first-page":"649","volume":"45","author":"US Centers for Disease Control and Pre","year":"1996","unstructured":"Centers for Disease Control and Prevention US. Fatalities associated with ingestion of diethylene glycol-contaminated glycerin used to manufacture acetaminophen syrup. MMWR Morbidity Mortal Wkly Rep. 1996;45:649\u201350.","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"key":"1184_CR10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/JS9.0000000000000059","volume":"109","author":"A MohanaSundaram","year":"2023","unstructured":"MohanaSundaram A, Padhi BK, Mohanty A, Shrestha S, Sah R. The silent epidemic of substandard and falsified medicines in low- and middle-income countries: Heed lessons from the tragic deaths of children in Indonesia. Int J Surg (London England). 2023;109:523\u20135.","journal-title":"Int J Surg (London England)"},{"key":"1184_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/JS9.0000000000000112","volume":"109","author":"AA Saied","year":"2023","unstructured":"Saied AA, Metwally AA, Dhama K. Gambian children\u2019s deaths due to contaminated cough syrups are a mutual responsibility. Int J Surg (London England). 2023;109:115\u20136.","journal-title":"Int J Surg (London England)"},{"key":"1184_CR12","doi-asserted-by":"crossref","first-page":"103432","DOI":"10.1016\/j.rechem.2026.103432","volume":"27","author":"M Shiferaw","year":"2026","unstructured":"Shiferaw M, Hymete A, Eticha T, Ashenef A. Ethylene glycol and diethylene glycol impurities determination and assay tests for selected pharmaceutical syrups collected from Addis Ababa, Ethiopia. Results Chem. 2026;27:103432.","journal-title":"Results Chem"},{"key":"1184_CR13","doi-asserted-by":"crossref","first-page":"465433","DOI":"10.1016\/j.chroma.2024.465433","volume":"1737","author":"S-T Zheng","year":"2024","unstructured":"Zheng S-T, Wang Z-Y, Liu Z, Du Y, Cao L, Tang S, Shi H-W. Rapid determination of trace ethylene glycol and diethylene glycol in propylene glycol-contained syrups by ultrahigh-performance supercritical fluid chromatography-mass spectrometry after precolumn derivatization. J Chromatogr A. 2024;1737:465433.","journal-title":"J Chromatogr A"},{"key":"1184_CR14","doi-asserted-by":"publisher","first-page":"39737","DOI":"10.1038\/s41598-025-26670-1","volume":"15","author":"BY Arman","year":"2025","unstructured":"Arman BY, Legge I, Walsby-Tickle J, Bharucha T, Gabel J, Gnegel G, Merchant HA. Rapid screening of ethylene glycol and diethylene glycol in raw materials and medicinal syrups using low-cost field deployable assays. Sci Rep. 2025;15:39737.","journal-title":"Sci Rep"},{"key":"1184_CR15","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use: ICH Harmonised Guideline: Validation of Analytical Procedures Q2(R2). In Book ICH Harmonised Guideline: Validation of Analytical Procedures Q2(R2) (Editor ed.^eds.). pp. 1\u201324. City. 2022:1\u201324."},{"key":"1184_CR16","unstructured":"Opinion of diethylene glycol. [https:\/\/ec.europa.eu\/health\/ph_risk\/committees\/04_sccp\/docs\/sccp_o_139.pdf]."},{"key":"1184_CR17","unstructured":"Indian Pharmacopoeia addendum. 2024 to Indian Pharmacopoeia 2022. [https:\/\/ipc.gov.in\/images\/Amendment_List_04_to_IP_2022.pdf]."},{"key":"1184_CR18","unstructured":"Testing of glycerin, propylene glycol, maltitol solution, hydrogenated starch hydrolysate, sorbitol solution, and other high-risk drug components for diethylene glycol and ethylene glycol. [https:\/\/www.fda.gov\/media\/167974\/download]."},{"key":"1184_CR19","unstructured":"Tests for diethylene glycol. and ethylene glycol in liquid preparations for oral use. [https:\/\/cdn.who.int\/media\/docs\/default-source\/medicines\/norms-and-standards\/current-projects\/2024-07-17-deg-eg-inliquidoraldosageforms-qas22-922rev4-up.pdf]."},{"key":"1184_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10728-023-00465-9","volume":"31","author":"H Ahamat","year":"2023","unstructured":"Ahamat H, Sa\u2019ban H, Manap NA. Balancing intellectual property protection and legal risk sssessment in registration of covid-19 vaccines in Malaysia. Health Care Anal. 2023;31:196\u2013207.","journal-title":"Health Care Anal"},{"key":"1184_CR21","first-page":"1","volume":"1","author":"HR Campbell","year":"2021","unstructured":"Campbell HR, Lodder RA. A brief review of FDA\u2019s Novel tools for ensuring pharmaceutical quality in the human drug supply chain. CIC Pharm Sci. 2021;1:1\u201310.","journal-title":"CIC Pharm Sci"},{"key":"1184_CR22","doi-asserted-by":"crossref","first-page":"1064003","DOI":"10.3389\/fmed.2022.1064003","volume":"9","author":"V Vignali","year":"2022","unstructured":"Vignali V, Hines PA, Cruz AG, Zi\u0119tek B, Herold R. Health horizons: Future trends and technologies from the European Medicines Agency\u2019s horizon scanning collaborations. Front Med. 2022;9:1064003.","journal-title":"Front Med"},{"key":"1184_CR23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s43441-023-00597-z","volume":"58","author":"A Mali","year":"2024","unstructured":"Mali A, Kuvar V, Bharadwaj S. Bridging the gap: A comparative investigation of pharmaceutical excipient regulations. Therapeutic Innov Regul Sci. 2024;58:258\u201372.","journal-title":"Therapeutic Innov Regul Sci"},{"key":"1184_CR24","doi-asserted-by":"crossref","unstructured":"Sahu M, Nandave M, Kumar A. Pharmacovigilance system in India. Pharmacovigilance essentials: advances, challenges and global perspectives. Springer; 2024:147\u201362.","DOI":"10.1007\/978-981-99-8949-2_7"},{"key":"1184_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/germs16020009","volume":"16","author":"MA Amil","year":"2026","unstructured":"Amil MA, Koo JH, Yah XY, Salam NA, Zakaria MM. Microbial contamination in hard-shell capsule traditional medicines and health supplements in Malaysia: GMP regulatory oversight and encapsulation practices. Germs. 2026;16:9.","journal-title":"Germs"},{"key":"1184_CR26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/cosmetics7020045","volume":"7","author":"H Hadi","year":"2020","unstructured":"Hadi H, Ihsan Awadh A, Zamli M, Ai Na, Jamshed S. Insight of Malaysian users of cosmetic regarding cosmetovigilance. Cosmetics. 2020;7:45.","journal-title":"Cosmetics"},{"key":"1184_CR27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1186\/s12889-022-13703-x","volume":"22","author":"R Panickar","year":"2022","unstructured":"Panickar R, Aziz Z, Kamarulzaman A. Enhancing medication risk communication in developing countries: A cross-sectional survey among doctors and pharmacists in Malaysia. BMC Public Health. 2022;22:1293.","journal-title":"BMC Public Health"},{"key":"1184_CR28","doi-asserted-by":"crossref","unstructured":"Feng K, Miranda AV, Obnial JC, Ebhodaghe ID, Lucero-Prisno DE III. Drug regulatory harmonization in the association of Southeast Asian Nations: is it time for an ASEAN medicines agency? A policy review. Clin Epidemiol Global Health. 2024;28.","DOI":"10.1016\/j.cegh.2024.101649"},{"key":"1184_CR29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s43441-020-00140-4","volume":"54","author":"NM Sani","year":"2020","unstructured":"Sani NM, McAuslane N, Kasbon SH, Ahmad R, Yusof FAM, Patel P. An evaluation of Malaysian regulatory process for new active substances approved in 2017 using the OpERA methodology. Therapeutic Innov Regul Sci. 2020;54:1215\u201324.","journal-title":"Therapeutic Innov Regul Sci"},{"key":"1184_CR30","doi-asserted-by":"crossref","first-page":"e0004024","DOI":"10.1371\/journal.pgph.0004024","volume":"5","author":"R Wilder","year":"2025","unstructured":"Wilder R, Halabi S, Gostin LO. Global and national actions to prevent trade in substandard and adulterated medicines. PLOS Global Public Health. 2025;5:e0004024.","journal-title":"PLOS Global Public Health"},{"key":"1184_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11306-018-1367-3","volume":"14","author":"D Broadhurst","year":"2018","unstructured":"Broadhurst D, Goodacre R, Reinke SN, Kuligowski J, Wilson ID, Lewis MR, Dunn WB. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics. 2018;14:72\u201389.","journal-title":"Metabolomics"},{"key":"1184_CR32","doi-asserted-by":"crossref","first-page":"180606","DOI":"10.5696\/2156-9614-8.18.180606","volume":"8","author":"AFI Apanpa-Qasim","year":"2018","unstructured":"Apanpa-Qasim AFI, Adeyi AA. Oxygenated volatile organic compounds (anti-freezing agents) in decorative water-based paints marketed in Nigeria. J Health Pollution. 2018;8:180606.","journal-title":"J Health Pollution"},{"key":"1184_CR33","unstructured":"Signal, noise, and detection limits in mass spectrometry. [https:\/\/www.agilent.com\/cs\/library\/technicaloverviews\/public\/5990-7651EN.pdf]."},{"key":"1184_CR34","doi-asserted-by":"crossref","first-page":"342695","DOI":"10.1016\/j.aca.2024.342695","volume":"1310","author":"X Zhu","year":"2024","unstructured":"Zhu X. A linear validation method of analytical procedures based on the double logarithm function linear fitting. Anal Chim Acta. 2024;1310:342695.","journal-title":"Anal Chim Acta"},{"key":"1184_CR35","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s11094-025-03472-3","volume":"59","author":"NA Lezhnina","year":"2025","unstructured":"Lezhnina NA, Khokhlov AL, Sidel\u2019nikov NA, Galeev RR, Somov DV, Basalaeva IA. Development and validation of a gas-chromatography\u2013mass-spectrometry method for quantitative determination of ethylene glycol and diethylene glycol in solutions for internal use and cough syrups. Pharm Chem J. 2025;59:920\u20134.","journal-title":"Pharm Chem J"},{"key":"1184_CR36","doi-asserted-by":"crossref","unstructured":"Hage DS. Chapter 8 - Chromatography and electrophoresis. In Contemporary Practice in Clinical Chemistry (Fourth Edition). Edited by Clarke W, Marzinke MA: Academic Press; 2019:135\u2013157.","DOI":"10.1016\/B978-0-12-815499-1.00008-9"},{"key":"1184_CR37","doi-asserted-by":"crossref","first-page":"104951","DOI":"10.1016\/j.arabjc.2023.104951","volume":"16","author":"W Wichitnithad","year":"2023","unstructured":"Wichitnithad W, Nantaphol S, Thitikornpong W, Rojsitthisak P. Development and validation of an LC-MS\/MS method for simultaneous determination of three organic azido impurities in tetrazole-containing sartans. Arab J Chem. 2023;16:104951.","journal-title":"Arab J Chem"},{"key":"1184_CR38","doi-asserted-by":"crossref","first-page":"116068","DOI":"10.1016\/j.trac.2020.116068","volume":"134","author":"F Raposo","year":"2021","unstructured":"Raposo F, Barcel\u00f3 D. Challenges and strategies of matrix effects using chromatography-mass spectrometry: An overview from research versus regulatory viewpoints. Trends Anal Chem. 2021;134:116068\u201377.","journal-title":"Trends Anal Chem"},{"key":"1184_CR39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0003-2670(02)01508-8","volume":"478","author":"L Cuadros-Rodr\u0131\u0301guez","year":"2003","unstructured":"Cuadros-Rodr\u0131\u0301guez L, Garc\u0131\u0301a-Campa\u00f1a AM, Almansa-L\u00f3pez E, Egea-Gonz\u00e1lez FJ, Lourdes Castro Cano M, Garrido Frenich A, Mart\u0131\u0301nez-Vidal JL. Correction function on biased results due to matrix effects: Application to the routine analysis of pesticide residues. Anal Chim Acta. 2003;478:281\u2013301.","journal-title":"Anal Chim Acta"},{"key":"1184_CR40","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1038\/s41598-023-36283-1","volume":"13","author":"ND Nisbar","year":"2023","unstructured":"Nisbar ND, Jamal Khair SK, Bujang NB, Mohd Yusop AY. Determination of ethanol, isopropyl alcohol and methanol in alcohol-based hand sanitiser to ensure product quality, safety and efficacy. Sci Rep. 2023;13:9478.","journal-title":"Sci Rep"},{"key":"1184_CR41","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.jcrs.2015.06.029","volume":"41","author":"C McAlinden","year":"2015","unstructured":"McAlinden C, Khadka J, Pesudovs K. Precision (repeatability and reproducibility) studies and sample-size calculation. J Cataract Refractive Surg. 2015;41:2598\u2013604.","journal-title":"J Cataract Refractive Surg"},{"key":"1184_CR42","unstructured":"WHO. Substandard (contaminated) syrup and suspension medicines identified in the WHO regions of the Americas, Eastern Mediterranean, South-east Asia and Western Pacific. https:\/\/www.who.int\/news\/item\/13-10-2025-medical-product-alert-n-5-2025--substandard-(contaminated)-oral-liquid-medicines."},{"key":"1184_CR43","doi-asserted-by":"crossref","first-page":"105715","DOI":"10.1016\/j.yrtph.2024.105715","volume":"153","author":"F Liu","year":"2024","unstructured":"Liu F. Safety assessment of drug impurities for patient safety: A comprehensive review. Regul Toxicol Pharmacol. 2024;153:105715\u201324.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1184_CR44","doi-asserted-by":"crossref","unstructured":"Silverstein I. Excipient manufacturing and good manufacturing practices. Excipient development for pharmaceutical, biotechnology, and drug delivery systems. CRC Press; 2006:393\u2013408.","DOI":"10.1201\/9781420004137-24"},{"key":"1184_CR45","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jps.24299","volume":"104","author":"VS Dave","year":"2015","unstructured":"Dave VS, Saoji SD, Raut NA, Haware RV. Excipient variability and its impact on dosage form functionality. J Pharm Sci. 2015;104:906\u201315.","journal-title":"J Pharm Sci"},{"key":"1184_CR46","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.xphs.2016.03.019","volume":"105","author":"CG Abrantes","year":"2016","unstructured":"Abrantes CG, Duarte D, Reis CP. An overview of pharmaceutical excipients: Safe or not safe? J Pharm Sci. 2016;105:2019\u201326.","journal-title":"J Pharm Sci"},{"key":"1184_CR47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/s22020447","volume":"22","author":"HY Chen","year":"2022","unstructured":"Chen HY, Chen C. Evaluation of calibration equations by using regression analysis: An example of chemical analysis. Sensors. 2022;22:447.","journal-title":"Sensors"},{"key":"1184_CR48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejfs.2014.07.001","volume":"5","author":"K-W Chan","year":"2015","unstructured":"Chan K-W. Tutorial on method verification: A routine method for the determination of heroin. Egypt J Forensic Sci. 2015;5:62\u20139.","journal-title":"Egypt J Forensic Sci"},{"key":"1184_CR49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmsacl.2024.07.002","volume":"33","author":"JM Goodwin","year":"2024","unstructured":"Goodwin JM, Kuiper HC, Brister B, Vesper HW. Impact of internal standard selection on measurement results for long chain fatty acids in blood. J Mass Spectrom Adv Clin Lab. 2024;33:22\u201330.","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"1184_CR50","doi-asserted-by":"crossref","first-page":"123518","DOI":"10.1016\/j.talanta.2022.123518","volume":"246","author":"A Korban","year":"2022","unstructured":"Korban A, \u010cabala R, Egorov V, Bos\u00e1kov\u00e1 Z, Charapitsa S. Evaluation of the variation in relative response factors of GC-MS analysis with the internal standard methods: Application for the alcoholic products quality control. Talanta. 2022;246:123518.","journal-title":"Talanta"},{"key":"1184_CR51","doi-asserted-by":"crossref","first-page":"40879","DOI":"10.1038\/s41598-025-24794-y","volume":"15","author":"J Yu","year":"2025","unstructured":"Yu J, An T, Chen D, Zong S, Bai D, Qi D, Shi J. Correction of gas chromatography\u2013mass spectrometry long-term instrumental drift using quality control samples over 155 days. Sci Rep. 2025;15:40879.","journal-title":"Sci Rep"},{"key":"1184_CR52","doi-asserted-by":"crossref","first-page":"115928","DOI":"10.1016\/j.ab.2025.115928","volume":"705","author":"D Tsikas","year":"2025","unstructured":"Tsikas D. Assessment of matrix effects in quantitative GC-MS by using isotopologs. Anal Biochem. 2025;705:115928.","journal-title":"Anal Biochem"},{"key":"1184_CR53","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3390\/molecules28062653","volume":"28","author":"E Tarakhovskaya","year":"2023","unstructured":"Tarakhovskaya E, Marcillo A, Davis C, Milkovska-Stamenova S, Hutschenreuther A, Birkemeyer C. Matrix effects in GC\u2013MS profiling of common metabolites after trimethylsilyl derivatization. Molecules. 2023;28:2653.","journal-title":"Molecules"},{"key":"1184_CR54","doi-asserted-by":"crossref","first-page":"2300571","DOI":"10.1002\/jssc.202300571","volume":"46","author":"ML Williams","year":"2023","unstructured":"Williams ML, Olomukoro AA, Emmons RV, Godage NH, Gionfriddo E. Matrix effects demystified: Strategies for resolving challenges in analytical separations of complex samples. J Sep Sci. 2023;46:2300571.","journal-title":"J Sep Sci"},{"key":"1184_CR55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00769-017-1251-2","volume":"22","author":"CE de Oliveira Pereira","year":"2017","unstructured":"de Oliveira Pereira CE, Souza MACe, Pianetti GA, de Souza SVC. Overview of proficiency testing provision in pharmaceutical area in Brazil and an educational scheme for determining mefenamic acid in raw materials. Accred Qual Assur. 2017;22:63\u201372.","journal-title":"Accred Qual Assur"},{"key":"1184_CR56","doi-asserted-by":"crossref","first-page":"20160032","DOI":"10.1515\/revac-2016-0032","volume":"36","author":"Y Liu","year":"2017","unstructured":"Liu Y, Lu F. Adulterated pharmaceutical chemicals in botanical dietary supplements: Novel screening approaches. Rev Anal Chem. 2017;36:20160032.","journal-title":"Rev Anal Chem"},{"key":"1184_CR57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/10408347.2021.1969887","volume":"53","author":"D Sonawane","year":"2023","unstructured":"Sonawane D, Kumar SA, Tarang J, Kumar TR, Sengupta P. Innovation in strategies for sensitivity improvement of chromatography and mass spectrometry based analytical techniques. Crit Rev Anal Chem. 2023;53:655\u201371.","journal-title":"Crit Rev Anal Chem"},{"key":"1184_CR58","doi-asserted-by":"crossref","first-page":"112935","DOI":"10.1016\/j.jpba.2019.112935","volume":"178","author":"EO Neves","year":"2020","unstructured":"Neves EO, de Sales PM, Silveira D. Pharmacopeial specifications and analytical data from post-marketing quality sampling and testing programs: A perspective beyond out-of-specification results. J Pharm Biomed Anal. 2020;178:112935.","journal-title":"J Pharm Biomed Anal"},{"key":"1184_CR59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijpharm.2015.05.066","volume":"491","author":"LX Yu","year":"2015","unstructured":"Yu LX, Woodcock J. FDA pharmaceutical quality oversight. Int J Pharm. 2015;491:2\u20137.","journal-title":"Int J Pharm"},{"key":"1184_CR60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jiph.2024.01.019","volume":"17","author":"AA Alahmari","year":"2024","unstructured":"Alahmari AA, Almuzaini Y, Alamri F, Alenzi R, Khan AA. Strengthening global health security through health early warning systems: A literature review and case study. J Infect Public Health. 2024;17:85\u201395.","journal-title":"J Infect Public Health"},{"key":"1184_CR61","doi-asserted-by":"crossref","first-page":"123342","DOI":"10.1016\/j.ijpharm.2023.123342","volume":"645","author":"C Anderson","year":"2023","unstructured":"Anderson C, Algorri M, Abernathy MJ. Real-time algorithmic exchange and processing of pharmaceutical quality data and information. Int J Pharm. 2023;645:123342.","journal-title":"Int J Pharm"},{"key":"1184_CR62","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s40264-021-01111-w","volume":"44","author":"P Bahri","year":"2021","unstructured":"Bahri P, Pariente A. Systematising pharmacovigilance engagement of patients, healthcare professionals and regulators: A practical decision guide derived from the international risk governance framework for engagement events and discourse. Drug Saf. 2021;44:1193\u2013208.","journal-title":"Drug Saf"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01184-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:39:35Z","timestamp":1792028375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01184-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01184-2","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed by the Medical Research and Ethics Committee (MREC) of the Ministry of Health Malaysia and granted an exemption, as the study did not involve human subjects or interventions (NMRR ID-25-02211-WXU).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"142"}}